Dr. Amit Garg shares his experience with the unique challenges of disease assessment and measuring treatment response in Hidradenitis Suppurativa. At Thalocan Research Innovations we collaborate with experts like Dr. Garg and Dr. John Ingram, among others, to develop tools and applications that improve the experience for trialists and patients, as well as optimizing the…
DetailsWe are grateful to Dr. Steve Daveluy for his comments regarding trainings provided by Thalocan Research Innovations, including our Hidradenitis Suppurativa Clinical Trial training led by Dr. Amit Garg and Dr. John Ingram. You can view a portion of that here or learn about our other training curriculums by visiting www.thalocan.com/trainings
More than 204 million people worldwide (or 2.6% of the world’s population) experience eczema. During October, we here at Thalocan Research Innovations are honored to join health organizations and dermatology groups work to continue to educate the public on eczema and reduce the stigma surrounding this chronic inflammatory skin condition. Of special note is the…
DetailsMeet (most) of the Thalocan Research Innovations team at SHSA 2025 in Nashville, the 10th annual symposium on Hidradenitis Supprativa. Here at TRI we are working alongside a number of KOLs including Dr. Amit Garg and Professor John Ingram, in creating technology and training to improve clinical trials and aid in the assessment and…
DetailsThalocan Research Innovations celebrates the fine work of the National Alopecia Areata Foundation and we are proud to spread awareness of their third annual Walk for Alopecia. (link to our blog) With Flagship Sites in San Francisco and Philadelphia, 20+ Volunteer Led Community Sites around the country, and locally activating do-it-yourself Walk Where You Are…
DetailsThalocan Research Innovations actively works with Physicians, Clinicians, leading experts and others who join us in our goal of revolutionizing clinical assessment of dermatological, among other of diseases. Our News Page at Thalocan.com (https://www.thalocan.com/news/) provides a wealth of insights, interviews, webinars, articles, case studies, videos, trainings, products and tools that are redefining the clinical trial…
DetailsVIVA LA THALOCAN! We’ve just heard from our Thalocan Research Innovations CEO Eric Zudak who is in attendance at the EADV Congress 2025 in Paris. He looks forward to sharing his insights and experiences regarding the latest science, research, and best practices across all areas of dermato-venereology. So much of what we offer here at…
DetailsAt Thalocan Research Innovations we pride ourselves on improving the quality of our trainings through creative collaboration with clinical researchers. Our team of graphic designers and animators provide the most effective and state-of-the-art visual support to meet all the needs of your customized training. Find out more at https://www.thalocan.com/trainings/
Thalocan Research Innovations and AGAPE Strategic Solutions of Maryland, LLC align on the significance of including patient perspectives and the social determinant of health in clinical research that includes the input of all relevant populations. Building trust in the engagement process and utilizing patient-centered tools to capture the accuracy of clinician and patient-reported outcomes help…
DetailsThalocan Research Innovations Creative Director, Paul Stroili discusses our recent company conference in Los Angeles, recognizing just some of the many who share our mission of revolutionizing the clinical assessment of dermatological diseases.
